Den årlige hyppighed af akut lungesvigt blev også reduceret med 25% til 33% ved behandling med hydroxycarbamid i adskillige studier.
The yearly frequency of acute chest syndrome was also reduced by 25 to 33% under hydroxycarbamide in several studies.